Conference Background and Objectives  
   
With the rapid advancement of biomedical technology, innovative technologies such as organ-on-a-chip, artificial intelligence, smart medical devices, and cell-derived new drugs have demonstrated immense potential in the fields of precision medicine and regenerative medicine. The application of these technologies can not only enhance medical outcomes but also significantly improve patients' quality of life. However, the research, development, and application of these emerging technologies also bring numerous regulatory compliance challenges. To address this, ISIMAC 2024 will gather domestic and international experts and industry leaders to jointly explore how to promote the regulatory compliance of innovative medical technologies while ensuring safety and efficacy.  
   
 Event Agenda  
   
The conference will officially begin at 9:00 am, starting with an opening ceremony featuring remarks from representatives of the Industrial Technology Department of the Ministry of Economic Affairs, the Institute for Information Industry (III) Technology Law Research Center, and Asia University. Subsequently, the conference will be divided into three thematic sessions for in-depth discussion:  
   
Session 1: Development and Application of Organ-on-a-Chip  
   
- 09:45 am - 10:15 am: International Medical Device Regulatory Trends, presented by Dr. Huang Yu-Ying, Head of the Biomedical Health Policy Division, III Technology Law Research Center.  
- 10:15 am - 10:45 am: Overview of Regulatory Management for Microfluidic Organ-on-a-Chip, presented by Li Xin-Jie, Reviewer at the Taiwan Food and Drug Administration (TFDA).  
- 10:45 am - 11:15 am: Alternative Platforms for Inhalation Testing Using Lung-on-a-Chip, presented by Professor Chen Guan-Yu of National Yang Ming Chiao Tung University.  
- 11:15 am - 11:45 am: Panel Discussion on the Development and Application Prospects of Organ-on-a-Chip, moderated by Assistant Professor Su Wen-Yu of Asia University.  
   
Session 2: Artificial Intelligence and Smart Medical Devices  
   
- 01:00 pm - 01:25 pm: Key Points of Smart Healthcare Regulations in Taiwan, presented by Wen Xin-Min, Legal Researcher at the III Technology Law Research Center.  
- 01:25 pm - 01:50 pm: Opportunities, Challenges, and Case Analysis of Digital Health, presented by Kuo Chih-Feng, Chief Strategy Officer of BioRay Medical Co., Ltd.  
- 01:50 pm - 02:15 pm: Smart Healthcare Solutions, presented by Song Zhen-Hua, Assistant Vice President of Quanta Computer Inc.  
- 02:10 pm - 02:45 pm: Panel Discussion on the Clinical Application Development of Innovative Smart Medical Devices, moderated by Professor Wang Chao-Neng of Asia University.  
   
Session 3: Design and Application of Cell-Derived New Drugs  
   
- 03:20 pm - 03:45 pm: Application of Mesenchymal Stem Cell-Derived Exosomes in Orthopedics, presented by Dr. Toh Wei Seong of the National University of Singapore.  
- 03:45 pm - 04:10 pm: First-in-Class Anti-inflammatory Exosome Therapy Targeting the NF-κB Pathway: From Lab to Clinic, presented by Dr. Chulhee Choi of ILIAS Biologics Inc.  
- 04:10 pm - 04:35 pm: Development and Clinical Translation of Exosome New Drugs, presented by Dr. Martin Sieber, Chief R&D Officer of Synlink Biotech Co., Ltd.  
- 04:35 pm - 05:00 pm: Panel Discussion on Development and Quality Control Challenges of Cell-Derived New Drugs, moderated by Associate Professor He Jia-Zhe of Asia University.  
   
 Guests and Speakers  
   
The conference will invite several renowned domestic and international experts and industry leaders, including Professor Wang Chao-Neng, Assistant Professor Su Wen-Yu, Associate Professor He Jia-Zhe, and Associate Professor Shen Yu-Fang from Asia University; Dr. Huang Yu-Ying and Legal Researcher Wen Xin-Min from the III Technology Law Research Center; Reviewer Li Xin-Jie from the Taiwan Food and Drug Administration; Professor Chen Guan-Yu from National Yang Ming Chiao Tung University; Chief Strategy Officer Kuo Chih-Feng from BioRay Medical Co., Ltd.; Assistant Vice President Song Zhen-Hua from Quanta Computer Inc.; Dr. Toh Wei Seong from the National University of Singapore; Dr. Chulhee Choi from ILIAS Biologics Inc.; and Dr. Martin Sieber from Synlink Biotech Co., Ltd.  
   
 Venue and Time  
   
The conference will be held on Wednesday, October 2, 2024, from 9:00 am to 5:00 pm at the Asia University International Conference Hall (A101), located at No. 500, Liu-Feng Road, Wufeng District, Taichung City.  
   
 Conclusion  
   
ISIMAC 2024 will provide a high-level exchange platform for regulatory compliance issues regarding innovative medical technologies, fostering collaboration between domestic and international experts and the industry to advance Taiwan's leading position in the global medical technology field. This conference is not only a feast of knowledge but also an opportunity to drive regulatory compliance for innovative medical technologies. We look forward to the active participation of all parties to jointly contribute to the development of advanced medicine in Taiwan.